Showing results (1591-1600 of 1,985) with videos related to

Sort By:
Pageof 199
The Lancet. Neurology|May 6, 2008
Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double-blind, pilot studyYining Huang, Yan Cheng, Jiang Wu, et al.
The Lancet. Neurology|April 19, 2008
Recent developments in childhood arterial ischaemic strokeCatherine Amlie-Lefond, Guillaume Sébire, Heather J Fullerton
The Lancet. Neurology|April 19, 2025
Amyotrophic lateral sclerosis caused by TARDBP mutations: from genetics to TDP-43 proteinopathyRubika Balendra, Jemeen Sreedharan, Martina Hallegger, et al.
The Lancet. Neurology|April 19, 2025
Pharmacotherapy and non-invasive neuromodulation for neuropathic pain: a systematic review and meta-analysisNadia Soliman, Xavier Moisset, Michael C Ferraro, et al.
The Lancet. Neurology|April 19, 2025
Biological effects of pathologies in Lewy body diseases: why timing mattersElie Matar, Glenda M Halliday
The Lancet. Neurology|January 24, 2026
Advances in biomarkers for diagnosis and prognosis of prion diseasesInga Zerr, Peter Hermann, Tze How Mok, et al.
The Lancet. Neurology|January 24, 2026
Genetic causes and modifiers of prion diseasesSimon Mead, Peter Hermann, Tze How Mok, et al.
The Lancet. Neurology|March 22, 2025
Intravenous thrombolysis before endovascular treatment versus endovascular treatment alone for patients with large vessel occlusion and carotid tandem lesions: individual participant data meta-analysis of six randomised trialsFabiano Cavalcante, Kilian Treurniet, Johannes Kaesmacher, et al.
The Lancet. Neurology|March 22, 2025
Multiple sclerosis and COVID-19: interactions and unresolved issuesAna Zabalza, Alan Thompson, Dalia L Rotstein, et al.
The Lancet. Neurology|March 15, 2013
Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trialRobert A Hauser, Ann Hsu, Sherron Kell, et al.
Pageof 199